Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 1982; Volume 21,Issue 2
  • You have access
    Conformational requirements of alpha 2-adrenergic receptors.
    R R Ruffolo, K S Anderson and D D Miller
    Molecular Pharmacology March 1982, 21 (2) 259-261;
  • You have access
    Production of hydroxyl radical by decomposition of superoxide spin-trapped adducts.
    E Finkelstein, G M Rosen and E J Rauckman
    Molecular Pharmacology March 1982, 21 (2) 262-265;
  • You have access
    Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique.
    A Pfeiffer and A Herz
    Molecular Pharmacology March 1982, 21 (2) 266-271;
  • You have access
    [3H]Etorphine receptor binding in vivo. Small fractional occupancy elicits analgesia.
    D C Perry, J S Rosenbaum, M Kurowski and W Sadée
    Molecular Pharmacology March 1982, 21 (2) 272-279;
  • You have access
    In vivo regulation of muscarinic cholinergic receptors in embryonic chick brain.
    M R Meyer, M W Gainer and N M Nathanson
    Molecular Pharmacology March 1982, 21 (2) 280-286;
  • You have access
    Cooperativity pattern in the interaction of the antiestrogen drug clomiphene with the Muscarinic receptors.
    G Ben-Baruch, G Schreiber and M Sokolovsky
    Molecular Pharmacology March 1982, 21 (2) 287-293;
  • You have access
    In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
    P M Laduron, P F Janssen, W Gommeren and J E Leysen
    Molecular Pharmacology March 1982, 21 (2) 294-300;
  • You have access
    [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.
    J E Leysen, C J Niemegeers, J M Van Nueten and P M Laduron
    Molecular Pharmacology March 1982, 21 (2) 301-314;
  • You have access
    Differential stereoselectivity of methotrimeprazine enantiomers for selected central nervous system receptor types.
    T A Robert, A N Hagardorn and E A Daigneault
    Molecular Pharmacology March 1982, 21 (2) 315-319;
  • You have access
    Interactions of barbiturates of various pharmacological categories with benzodiazepine receptors.
    F Leeb-Lundberg and R W Olsen
    Molecular Pharmacology March 1982, 21 (2) 320-328;
  • You have access
    Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes.
    R R Goodman, M J Cooper, M Gavish and S H Snyder
    Molecular Pharmacology March 1982, 21 (2) 329-335;
  • You have access
    Stimulation of a low Km GTPase by inhibitors of adipocyte adenylate cyclase.
    K Aktories, G Schultz and K H Jakobs
    Molecular Pharmacology March 1982, 21 (2) 336-342;
  • You have access
    Structure of the saxitoxin binding site at sodium channels in nerve membranes. Exchange of tritium from bound toxin molecules.
    G Strichartz
    Molecular Pharmacology March 1982, 21 (2) 343-350;
  • You have access
    Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes.
    C E Spivak, M A Maleque, A C Oliveira, L M Masukawa, T Tokuyama, J W Daly and E X Albuquerque
    Molecular Pharmacology March 1982, 21 (2) 351-361;
  • You have access
    Characterization of serotonin uptake in cultured neuroblastoma cells. Difference between differentiated and nondifferentiated cells.
    J R Yoffe and R T Borchardt
    Molecular Pharmacology March 1982, 21 (2) 362-367;
  • You have access
    Characterization of serotonin uptake in cultured pheochromocytoma cells. Comparison with norepinephrine uptake.
    J R Yoffe and R T Borchardt
    Molecular Pharmacology March 1982, 21 (2) 368-373;
  • You have access
    A structure-activity study of the transport sites for the hypothalamic and striatal catecholamine uptake systems. Similarities and differences.
    S B Eckhardt, R A Maxwell and R M Ferris
    Molecular Pharmacology March 1982, 21 (2) 374-379;
  • You have access
    Chemical transformations of xylamine (N-2'-chloroethyl-N-ethyl-2-methylbenzylamine) in solution. Pharmacological activity of the species derived from this irreversible norepinephrine uptake inhibitor.
    R W Ransom, R C Kammerer and A K Cho
    Molecular Pharmacology March 1982, 21 (2) 380-386;
  • You have access
    Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    K J Fehske, U Schläfer, U Wollert and W E Müller
    Molecular Pharmacology March 1982, 21 (2) 387-393;
  • You have access
    Structure-activity relationships in the ansamycins. Molecular structure and activity of 3-carbomethoxy rifamycin S.
    M Brufani, L Cellai, S Cerrini, W Fedeli, A Segre and A Vaciago
    Molecular Pharmacology March 1982, 21 (2) 394-399;
  • You have access
    Comparison of crystallographic and quantum mechanical analysis with biological data on clonidine and some related analogues.
    A Carpy, J M Leger, G Leclerc, N Decker, B Rouot and C G Wermuth
    Molecular Pharmacology March 1982, 21 (2) 400-408;
  • You have access
    Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidation.
    S G Dahl, M Hjorth and E Hough
    Molecular Pharmacology March 1982, 21 (2) 409-414;
  • You have access
    Magnesium-dependent inhibition of beef heart soluble mitochondrial adenosine triphosphatase by tricyclic antipsychotics.
    P Palatini
    Molecular Pharmacology March 1982, 21 (2) 415-421;
  • You have access
    Effects of the calmodulin antagonist trifluoperazine on stimulus-induced calcium mobilization, aggregation, secretion, and protein phosphorylation in platelets.
    M B Feinstein and R A Hadjian
    Molecular Pharmacology March 1982, 21 (2) 422-431;
  • You have access
    Differential phosphorylation of (E)-5-(2-bromovinyl)-2'-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus.
    J A Fyfe
    Molecular Pharmacology March 1982, 21 (2) 432-437;
  • You have access
    Rates of alcohol dehydrogenase-dependent ethanol metabolism in periportal and pericentral regions of the perfused rat liver.
    T Kashiwagi, S Ji, J J Lemasters and R G Thurman
    Molecular Pharmacology March 1982, 21 (2) 438-443;
  • You have access
    Cysteine S-conjugate N-acetyltransferase from rat kidney microsomes.
    M W Duffel and W B Jakoby
    Molecular Pharmacology March 1982, 21 (2) 444-448;
  • You have access
    Induction and modification of rat liver microsomal arylamide N-hydroxylase by various pretreatments.
    C Razzouk, M Batardy-Grégoire and M Roberfroid
    Molecular Pharmacology March 1982, 21 (2) 449-457;
  • You have access
    Norcocaine nitroxide. A potential hepatotoxic metabolite of cocaine.
    E J Rauckman, G M Rosen and J Cavagnaro
    Molecular Pharmacology March 1982, 21 (2) 458-463;
  • You have access
    Inhibition of rat liver cytochrome P-450 by benzyl hydrodisulfide.
    T Sawahata and R A Neal
    Molecular Pharmacology March 1982, 21 (2) 464-467;
  • You have access
    Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
    R I Glazer and L S Lloyd
    Molecular Pharmacology March 1982, 21 (2) 468-473;
  • You have access
    In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
    W C Tseng, D Derse, Y C Cheng, R W Brockman and L L Bennett
    Molecular Pharmacology March 1982, 21 (2) 474-477;
  • You have access
    Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells.
    B A Domin, S P Grill, K F Bastow and Y C Cheng
    Molecular Pharmacology March 1982, 21 (2) 478-482;
  • You have access
    Comparison of opiate inhibition of adenylate cyclase activity in neuroblastoma N18tG2 and neuroblastoma x glioma NG108-15 hybrid cell lines.
    P Y Law, J E Koehler and H H Loh
    Molecular Pharmacology March 1982, 21 (2) 483-491;
  • You have access
    Potentiation of opiate action in neuroblastoma N18TG2 cells by lipid incorporation.
    P Y Law, T D Nicksic, M A O'Rourke, J E Koehler, A Herz and H H Loh
    Molecular Pharmacology March 1982, 21 (2) 492-502;
  • You have access
    Cyclic AMP receptors and cation fluxes in the turkey erythrocyte.
    S A Rudolph, T M Baird and J W Wardell
    Molecular Pharmacology March 1982, 21 (2) 503-510;
  • You have access
    Differential inducibility of nuclear envelope epoxide hydratase by trans-stilbene oxide and phenobarbital.
    F J Gonzalez and C B Kasper
    Molecular Pharmacology March 1982, 21 (2) 511-516;
  • You have access
    Cytochrome P-450 and monooxygenase activity in cardiac microsomes from the fish Stenotomus chrysops.
    J J Stegeman, B R Woodin, A V Klotz, R E Wolke and N R Orme-Johnson
    Molecular Pharmacology March 1982, 21 (2) 517-526;
  • You have access
    Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction.
    L M Bornheim and M R Franklin
    Molecular Pharmacology March 1982, 21 (2) 527-532;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 21, Issue 2
1 Mar 1982
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics